We are conducting clinical trials with our four SPEAR T-cells therapies (ADP-A2M4, ADP-A2AFP, ADP-A2M4CD8 and ADP-A2M10) in ten cancers. The purpose of this section is to serve as an introduction for patients who might be interested in our current trials. Below is a list of the trials we are conducting with links to the clinicaltrials.gov pages, where you can find more details about each trial including participating clinical trial sites.
In each section, you will also find information about the various cancer types we are investigating, and details about participating in our trials.
For more details on the technology, development, and product pipeline, please visit the corresponding pages on our site.
For patient inquiries, please contact firstname.lastname@example.org